Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank79
3Y CAGR+54.8%
5Y CAGR+4.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+54.8%/yr
vs -13.5%/yr prior
5Y CAGR
+4.6%/yr
Recent acceleration
Acceleration
+68.3pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.56 | +158.0% |
| 2024 | 1.38 | -43.6% |
| 2023 | 2.44 | +154.8% |
| 2022 | 0.96 | -66.6% |
| 2021 | 2.88 | +1.4% |
| 2020 | 2.84 | +101.6% |
| 2019 | -176.84 | -10439.0% |
| 2018 | 1.71 | +5.6% |
| 2017 | 1.62 | +127.2% |
| 2016 | 0.71 | - |